OL~~ON, PHILIP C. OLSSON RICHARD L. FRANK DAVID E WEEDA[removed]DENNIS R JOHNSON ARTHUR ‘r: TSIEN

First Page		Document Content
Date: 2004-12-27 14:08:29 Food and Drug Administration Clinical research Pharmaceuticals policy Pharmaceutical industry Abbreviated New Drug Application New Drug Application Federal Food Drug and Cosmetic Act Ondansetron Bioequivalence Pharmaceutical sciences Pharmacology Medicine		OL~~ON, PHILIP C. OLSSON RICHARD L. FRANK DAVID E WEEDA[removed]DENNIS R JOHNSON ARTHUR ‘r: TSIEN Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 541,98 KB Share Document on Facebook

	NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato DocID: 1uASt - View Document
	Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DocID: 1tBOU - View Document
	RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson DocID: 1roDS - View Document
	Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration DocID: 1rmMY - View Document
	Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff DocID: 1r7Xt - View Document